DIVISLAB

Divi's Laboratories vs Peers

₹9,586.00+0.38%
Market cap
₹2.54 lakh crore
P/E
87.0
P/B
15.18
ROE
16.2%
Dividend yield
0.31%

Divi's Laboratories ranks 2nd by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Torrent Pharmaceuticals and Zydus Lifesciences. Its P/E of 87.0 compares with a peer median of 33.6.

Divi's Laboratories vs Pharmaceuticals peers

Sorted by market capitalisation.

Divi's Laboratories and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Sun Pharmaceutical Industries1,773.60-1.69%4,25,54635.25.0914.7%+12.5%
Divi's Laboratories9,586.00+0.38%2,54,47887.015.1816.2%+22.0%
Torrent Pharmaceuticals4,693.90-1.64%1,58,86372.818.9427.1%+12.5%
Zydus Lifesciences1,151.30-0.71%1,15,84825.74.2719.7%+12.5%
Laurus Labs2,052.90+0.14%1,10,827101.420.9118.2%+12.5%
Cipla1,333.00-0.54%1,07,67732.03.1311.8%+12.5%
Mankind Pharma2,496.00-0.16%1,03,04250.46.3212.5%+12.5%
Dr. Reddy's Laboratories1,194.90-1.08%99,53330.12.6012.1%+12.5%
Aurobindo Pharma1,677.90-0.88%97,45326.32.579.9%+12.5%
Lupin2,006.70-1.11%91,74216.64.0926.9%+12.5%
Glenmark Pharmaceuticals2,286.10-1.08%64,51435.96.1414.1%+12.5%

Compare Divi's Laboratories side by side

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

Divi's Laboratories peer comparison — frequently asked questions

Who are Divi's Laboratories' competitors?

Divi's Laboratories' listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs, Cipla and Mankind Pharma, ranked here by market capitalisation.

How does Divi's Laboratories' P/E compare with its peers?

Divi's Laboratories trades at a P/E of 87.0, against a median of 33.6 across the 10 Pharmaceuticals peers shown.

Which is the largest company among Divi's Laboratories' peers?

By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹2.54 lakh crore for Divi's Laboratories.

Same Data For Peers

Trade Divi's Laboratories With ATS

Track DIVISLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.